What is Ashley Jenkins's NPI number?

Ashley Jenkins's National Provider Identifier (NPI) is 1104239037, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Ashley Jenkins's specialty?

Ashley Jenkins is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Ashley Jenkins located?

Ashley Jenkins's practice location on file with NPPES is 4230 Philips Farm Rd, Columbia, MO 65201-0067.

What is Ashley Jenkins's phone number?

The practice phone number listed in the NPPES registry for Ashley Jenkins is (573) 882-4800.

Does Ashley Jenkins accept Medicare?

Ashley Jenkins is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Ashley Jenkins's NPI active?

Yes — Ashley Jenkins's NPI (1104239037) is active in the NPPES registry as of the last update on 2024-02-12.

IndividualActiveAccepts Medicare

Ashley Jenkins, M.D.

NPI 1104239037 · Dermatology Physician · Columbia, MO

Ashley Jenkins, M.D. is a Dermatology Physician provider in Columbia, MO (NPI 1104239037).

Provider details

NPI number: 1104239037
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: 2018001302 (MO)

Practice location

4230 Philips Farm Rd

Columbia, MO 65201-0067

Phone: (573) 882-4800

Fax: (573) 884-0723

Approximate (ZIP-level) locationGet directions

More MO providers

Mailing address

Po Box 843966

Kansas City, MO 64184-3966

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2018001302 (MO)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(62/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
12 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
860 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	250	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	162	$62
Destruction of Precancer Skin Growth, 1 Growth17000	117	$43
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	114	$90
Destruction of Skin Growth, 1-14 Growths17110	58	$58
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	82	28
Triamcinolone Acetonide	50	28
Clobetasol Propionate	41	24
Clindamycin Phosphate	24	—
Spironolactone	22	—
Doxycycline Hyclate	18	—
Dupilumabbrand: Dupixent Pen	16	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$149 across 7 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2014-06-09
Last updated: 2024-02-12
Certified: 2024-02-12

Frequently asked questions

What is Ashley Jenkins's NPI number?: Ashley Jenkins's National Provider Identifier (NPI) is 1104239037, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Ashley Jenkins's specialty?: Ashley Jenkins is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Ashley Jenkins located?: Ashley Jenkins's practice location on file with NPPES is 4230 Philips Farm Rd, Columbia, MO 65201-0067.
What is Ashley Jenkins's phone number?: The practice phone number listed in the NPPES registry for Ashley Jenkins is (573) 882-4800.
Does Ashley Jenkins accept Medicare?: Ashley Jenkins is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Ashley Jenkins's NPI active?: Yes — Ashley Jenkins's NPI (1104239037) is active in the NPPES registry as of the last update on 2024-02-12.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	250	$2
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	162	$62
Destruction of Precancer Skin Growth, 1 Growth17000	117	$43
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	114	$90
Destruction of Skin Growth, 1-14 Growths17110	58	$58
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

Triamcinolone Acetonide

Clobetasol Propionate

Clindamycin Phosphate

—

Spironolactone

—

Doxycycline Hyclate

—

Dupilumabbrand: Dupixent Pen

—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$149 across 7 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments